220 related articles for article (PubMed ID: 31222811)
21. HSP27, 70 and 90, anti-apoptotic proteins, in clinical cancer therapy (Review).
Wang X; Chen M; Zhou J; Zhang X
Int J Oncol; 2014 Jul; 45(1):18-30. PubMed ID: 24789222
[TBL] [Abstract][Full Text] [Related]
22. Heat shock protects HCT116 and H460 cells from TRAIL-induced apoptosis.
Ozören N; El-Deiry W
Exp Cell Res; 2002 Dec; 281(2):175-81. PubMed ID: 12460647
[TBL] [Abstract][Full Text] [Related]
23. The androgen receptor antagonist enzalutamide induces apoptosis, dysregulates the heat shock protein system, and diminishes the androgen receptor and estrogen receptor β1 expression in prostate cancer cells.
Abazid A; Martin B; Choinowski A; McNeill RV; Brandenburg LO; Ziegler P; Zimmermann U; Burchardt M; Erb H; Stope MB
J Cell Biochem; 2019 Oct; 120(10):16711-16722. PubMed ID: 31297844
[TBL] [Abstract][Full Text] [Related]
24. A novel association between the human heat shock transcription factor 1 (HSF1) and prostate adenocarcinoma.
Hoang AT; Huang J; Rudra-Ganguly N; Zheng J; Powell WC; Rabindran SK; Wu C; Roy-Burman P
Am J Pathol; 2000 Mar; 156(3):857-64. PubMed ID: 10702402
[TBL] [Abstract][Full Text] [Related]
25. Apoptosis versus cell differentiation: role of heat shock proteins HSP90, HSP70 and HSP27.
Lanneau D; de Thonel A; Maurel S; Didelot C; Garrido C
Prion; 2007; 1(1):53-60. PubMed ID: 19164900
[TBL] [Abstract][Full Text] [Related]
26. Camptothecin disrupts androgen receptor signaling and suppresses prostate cancer cell growth.
Liu S; Yuan Y; Okumura Y; Shinkai N; Yamauchi H
Biochem Biophys Res Commun; 2010 Apr; 394(2):297-302. PubMed ID: 20206136
[TBL] [Abstract][Full Text] [Related]
27. Chemical ablation of androgen receptor in prostate cancer cells by the histone deacetylase inhibitor LAQ824.
Chen L; Meng S; Wang H; Bali P; Bai W; Li B; Atadja P; Bhalla KN; Wu J
Mol Cancer Ther; 2005 Sep; 4(9):1311-9. PubMed ID: 16170022
[TBL] [Abstract][Full Text] [Related]
28. Expression of heat shock proteins in brain tumors.
Alexiou GA; Karamoutsios A; Lallas G; Ragos V; Goussia A; Kyritsis AP; Voulgaris S; Vartholomatos G
Turk Neurosurg; 2014; 24(5):745-9. PubMed ID: 25269047
[TBL] [Abstract][Full Text] [Related]
29. Targeting heat shock proteins in cancer.
Jego G; Hazoumé A; Seigneuric R; Garrido C
Cancer Lett; 2013 May; 332(2):275-85. PubMed ID: 21078542
[TBL] [Abstract][Full Text] [Related]
30. Heat-shock protein expression in leukemia.
Sedlackova L; Spacek M; Holler E; Imryskova Z; Hromadnikova I
Tumour Biol; 2011 Feb; 32(1):33-44. PubMed ID: 20694586
[TBL] [Abstract][Full Text] [Related]
31. Downregulation of androgen receptor expression by luteolin causes inhibition of cell proliferation and induction of apoptosis in human prostate cancer cells and xenografts.
Chiu FL; Lin JK
Prostate; 2008 Jan; 68(1):61-71. PubMed ID: 18008333
[TBL] [Abstract][Full Text] [Related]
32. Abrogation of heat-shock protein (HSP)70 expression induced cell growth inhibition and apoptosis in human androgen-independent prostate cancer cell line PC-3m.
Zhao ZG; Ma QZ; Xu CX
Asian J Androl; 2004 Dec; 6(4):319-24. PubMed ID: 15546023
[TBL] [Abstract][Full Text] [Related]
33. Hsp-27 and NF-κB pathway is associated with AR/AR-V7 expression in prostate cancer cells.
Kiliccioglu I; Konac E; Dikmen AU; Sozen S; Bilen CY
Gene; 2019 May; 697():138-143. PubMed ID: 30807779
[TBL] [Abstract][Full Text] [Related]
34. VER-155008, a small molecule inhibitor of HSP70 with potent anti-cancer activity on lung cancer cell lines.
Wen W; Liu W; Shao Y; Chen L
Exp Biol Med (Maywood); 2014 May; 239(5):638-45. PubMed ID: 24676905
[TBL] [Abstract][Full Text] [Related]
35. 17-Allylamino-17-demethoxygeldanamycin induces the degradation of androgen receptor and HER-2/neu and inhibits the growth of prostate cancer xenografts.
Solit DB; Zheng FF; Drobnjak M; Münster PN; Higgins B; Verbel D; Heller G; Tong W; Cordon-Cardo C; Agus DB; Scher HI; Rosen N
Clin Cancer Res; 2002 May; 8(5):986-93. PubMed ID: 12006510
[TBL] [Abstract][Full Text] [Related]
36. A novel, small molecule inhibitor of Hsc70/Hsp70 potentiates Hsp90 inhibitor induced apoptosis in HCT116 colon carcinoma cells.
Massey AJ; Williamson DS; Browne H; Murray JB; Dokurno P; Shaw T; Macias AT; Daniels Z; Geoffroy S; Dopson M; Lavan P; Matassova N; Francis GL; Graham CJ; Parsons R; Wang Y; Padfield A; Comer M; Drysdale MJ; Wood M
Cancer Chemother Pharmacol; 2010 Aug; 66(3):535-45. PubMed ID: 20012863
[TBL] [Abstract][Full Text] [Related]
37. Cotargeting HSP90 and Its Client Proteins for Treatment of Prostate Cancer.
Chen L; Li J; Farah E; Sarkar S; Ahmad N; Gupta S; Larner J; Liu X
Mol Cancer Ther; 2016 Sep; 15(9):2107-18. PubMed ID: 27390342
[TBL] [Abstract][Full Text] [Related]
38. Phosphorylation of HSP90 by protein kinase A is essential for the nuclear translocation of androgen receptor.
Dagar M; Singh JP; Dagar G; Tyagi RK; Bagchi G
J Biol Chem; 2019 May; 294(22):8699-8710. PubMed ID: 30992362
[TBL] [Abstract][Full Text] [Related]
39. 6-(3,4-Dihydro-1H-isoquinoline-2-yl)-N-(6-methoxypyridine-2-yl) nicotinamide-26 (DIMN-26) decreases cell proliferation by induction of apoptosis and downregulation of androgen receptor signaling in human prostate cancer cells.
Choi HE; Shin JS; Leem DG; Kim SD; Cho WJ; Lee KT
Chem Biol Interact; 2016 Dec; 260():196-207. PubMed ID: 27720946
[TBL] [Abstract][Full Text] [Related]
40. Cell Stress Induced Stressome Release Including Damaged Membrane Vesicles and Extracellular HSP90 by Prostate Cancer Cells.
Eguchi T; Sogawa C; Ono K; Matsumoto M; Tran MT; Okusha Y; Lang BJ; Okamoto K; Calderwood SK
Cells; 2020 Mar; 9(3):. PubMed ID: 32204513
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
